why is the fda banning tirzepatide Grants a New Indication for Obesity Management FDA Approves Tirzepatide, A Potential

Women using weight loss injections may experience menstrual changes including longer or shorter cycles, heavier or lighter bleeding, or missed periods entirely

Melanocyte stimulating hormone peptides inhibit TNF-alpha signaling in human dermal fibroblast cells

With one-year REVEAL-1 data now showing durable weight maintenance after a single Revita procedure, and without any continued drug therapy, we believe Revita points to a fundamentally different path: a potentially one-time, root-cause approach to holding onto weight loss after GLP-1 discontinuation

Severe safety risks, including fire or explosion (explore lithium battery explosion)

This research reinforces what we've long understood in functional medicine: the body's systems are interconnected, and addressing root causes can have far-reaching healing effects

Whether hunger or cravings have crept back in, which can be a clue that your dose needs more support